Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky)· @TiansterZhang · X·· 2 days agoScore70
Body · original
#RandySweis showing data from EV-SG-zim in 1st line met #urothelialcancer — small sample size but high ORR 81% including 3 pts w CRs. Pushing depth of response for met UC.
@oncoalert #ESMO26 @myESMO
464 views · 8 likes · 8 reposts · 0 replies
Conference abstracts
1017Pmatched by Developmental therapeutics
Phase 1 first-in-human (FIH) results of YL211, a c-Met targeting antibody-drug conjugate (ADC), in patients (pts) with advanced solid tumors
https://esmocongress.esmo.orgNCT06110663NCT06110663matched by - **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
- **标题 / Title：** A Study of HS-10241 Combined With Almonertinib Versus Platinum-based Chemotherapy in Treatment of Advanced NSCLC With MET Amplification After Failure of EGFR-TKI Therapy
https://esmocongress.esmo.orgSource: Tian Zhang, MD, MHS, FASCO (@tiansterzhangmd.bsky) · x.com